Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biorigin is a Brazilian biotechnology company specializing in the production of natural-origin ingredients derived from Saccharomyces cerevisiae yeast for human food, pet food, and animal nutrition. The company's portfolio includes yeast extracts, prebiotics (MOS), beta-glucans, proteins, and flavor enhancers. Its products aim to improve nutrition profiles—such as reducing sodium or sugar—and enhance palatability and health benefits in foods for people and animals. With over two decades of experience and global reach across more than 60 countries, Biorigin emphasizes sustainability through renewable energy use and traceable supply chains[1][2][3][4][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biorigin.